Loading
Radiation oncologist who led intraoperative radiotherapy trials and directs research at IEO.
Roberto Orecchia is Scientific Director of IEO, the European Institute of Oncology, in Milan. A radiation oncologist, his specialisms are radiation oncology, intraoperative radiotherapy and proton therapy, alongside modern image-guided external beam techniques. He led ELIOT, the randomised phase 3 equivalence trial of intraoperative electron radiotherapy in early breast cancer, whose long-term recurrence outcomes were reported in The Lancet Oncology. His other papers include a study of seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2, and a review of machine learning models for predicting toxicity outcomes in radiotherapy. His publications are listed on PubMed.
| Title | Journal | Year |
|---|---|---|
| Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial | The Lancet Oncology | 2021 |
| Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2 | Annals of Oncology | 2021 |
| Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy | Frontiers in Oncology | 2020 |